Procedure for the diagnosis of sepsis and severe infections by determining soluble cytokeratin 1 fragments

摘要

Use of novel soluble cytokeratin 1 fragments from body fluids or body tissues as marker peptides for the diagnosis, prognosis and monitoring of the course of inflammations and infections and/or as a target for the therapeutic influencing of the course of inflammations and/or infections.